首页 > 最新文献

Kinases and phosphatases最新文献

英文 中文
A Critical Look at the Crystal Structures of cAMP-Dependent Protein Kinases. 对camp依赖性蛋白激酶晶体结构的批判性观察。
Pub Date : 2025-09-01 Epub Date: 2025-09-11 DOI: 10.3390/kinasesphosphatases3030019
Alexander Wlodawer, Pawel Rubach, Zbigniew Dauter, Wojciech Dec, Wladek Minor, Dariusz Brzezinski, Mariusz Jaskolski

We have evaluated the quality of all 325 deposits in the PDB (as of December 2024) that correspond to (or contain) the catalytic domain of cAMP-dependent protein kinases (PKA). Detailed analysis was possible for 289 deposits of crystal structures that included not only the atomic coordinates but also structure factors. These structures represent 35 years of studies, and it is not surprising that the more recent structures are generally of better quality than the older ones. We did not encounter deposits with very severe problems, although some minor problems were found. To assess whether a uniform method of structure re-refinement, as implemented in the pipeline and website PDB-REDO, leads to significant improvement of structural models, we compared structure quality indicators for the originally refined structures and their counterparts resulting from PDB-REDO refinement. The re-refinement procedure significantly improved only some older structures, while its success was generally limited. We paid particular attention to the quality of small-molecule ligands, finding that most of them fit the electron density very well. This type of analysis helps identify the highest quality structures among many deposits for certain protein families and, thus, could be extended to other groups of proteins as well.

我们已经评估了PDB中所有325个沉积物的质量(截至2024年12月),这些沉积物对应(或包含)camp依赖性蛋白激酶(PKA)的催化结构域。对289种沉积的晶体结构进行了详细的分析,不仅包括原子坐标,还包括结构因素。这些结构代表了35年的研究,并不奇怪,较新的结构通常比较旧的结构质量更好。虽然发现了一些小问题,但我们没有遇到非常严重的问题。为了评估在管道和网站PDB-REDO中实施的统一的结构再细化方法是否会导致结构模型的显着改进,我们比较了最初细化的结构和PDB-REDO细化后的结构质量指标。重新改进程序仅显著改善了一些较旧的结构,而其成功通常是有限的。我们特别注意了小分子配体的质量,发现它们中的大多数都非常适合电子密度。这种类型的分析有助于在某些蛋白质家族的许多沉积物中确定最高质量的结构,因此也可以扩展到其他蛋白质组。
{"title":"A Critical Look at the Crystal Structures of cAMP-Dependent Protein Kinases.","authors":"Alexander Wlodawer, Pawel Rubach, Zbigniew Dauter, Wojciech Dec, Wladek Minor, Dariusz Brzezinski, Mariusz Jaskolski","doi":"10.3390/kinasesphosphatases3030019","DOIUrl":"10.3390/kinasesphosphatases3030019","url":null,"abstract":"<p><p>We have evaluated the quality of all 325 deposits in the PDB (as of December 2024) that correspond to (or contain) the catalytic domain of cAMP-dependent protein kinases (PKA). Detailed analysis was possible for 289 deposits of crystal structures that included not only the atomic coordinates but also structure factors. These structures represent 35 years of studies, and it is not surprising that the more recent structures are generally of better quality than the older ones. We did not encounter deposits with very severe problems, although some minor problems were found. To assess whether a uniform method of structure re-refinement, as implemented in the pipeline and website PDB-REDO, leads to significant improvement of structural models, we compared structure quality indicators for the originally refined structures and their counterparts resulting from PDB-REDO refinement. The re-refinement procedure significantly improved only some older structures, while its success was generally limited. We paid particular attention to the quality of small-molecule ligands, finding that most of them fit the electron density very well. This type of analysis helps identify the highest quality structures among many deposits for certain protein families and, thus, could be extended to other groups of proteins as well.</p>","PeriodicalId":74042,"journal":{"name":"Kinases and phosphatases","volume":"3 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12478544/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145202220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SMURF1/2 Are Novel Regulators of WNK1 Stability. SMURF1/2是WNK1稳定性的新调控因子。
Pub Date : 2024-09-01 Epub Date: 2024-09-20 DOI: 10.3390/kinasesphosphatases2030019
Ankita B Jaykumar, Sakina Plumber, Derk Binns, Chonlarat Wichaidit, Katherine Luby-Phelps, Melanie H Cobb

Angiogenesis is essential for remodeling and repairing existing vessels, and this process requires signaling pathways including those controlled by transforming growth factor beta (TGF-β). We have previously reported crosstalk between TGF-β and the protein kinase With No lysine (K) 1 (WNK1). Homozygous disruption of the gene encoding WNK1 results in lethality in mice near embryonic day E12 due to impaired angiogenesis, and this defect can be rescued by the endothelial-specific expression of an activated form of the WNK1 substrate kinase Oxidative Stress-Responsive 1 (OSR1). However, molecular processes regulated via a collaboration between TGF-β and WNK1/OSR1 are not well understood. Here, we show that WNK1 interacts with the E3 ubiquitin ligases SMURF1/2. In addition, we discovered that WNK1 regulates SMURF1/2 protein stability and vice versa. We also demonstrate that WNK1 activity regulates TGF-β receptor levels, in turn, controlling TGF-β signaling.

血管生成对现有血管的重塑和修复至关重要,这一过程需要包括转化生长因子β (TGF-β)控制的信号通路。我们之前报道了TGF-β和无赖氨酸(K) 1蛋白激酶(WNK1)之间的串扰。编码WNK1基因的纯合子破坏会导致胚胎期E12小鼠因血管生成受损而死亡,这种缺陷可以通过激活形式的WNK1底物激酶氧化应激反应1 (OSR1)的内皮特异性表达来修复。然而,通过TGF-β和WNK1/OSR1之间的合作调节的分子过程尚不清楚。在这里,我们发现WNK1与E3泛素连接酶SMURF1/2相互作用。此外,我们发现WNK1调节SMURF1/2蛋白的稳定性,反之亦然。我们还证明WNK1活性调节TGF-β受体水平,进而控制TGF-β信号传导。
{"title":"SMURF1/2 Are Novel Regulators of WNK1 Stability.","authors":"Ankita B Jaykumar, Sakina Plumber, Derk Binns, Chonlarat Wichaidit, Katherine Luby-Phelps, Melanie H Cobb","doi":"10.3390/kinasesphosphatases2030019","DOIUrl":"10.3390/kinasesphosphatases2030019","url":null,"abstract":"<p><p>Angiogenesis is essential for remodeling and repairing existing vessels, and this process requires signaling pathways including those controlled by transforming growth factor beta (TGF-β). We have previously reported crosstalk between TGF-β and the protein kinase With No lysine (K) 1 (WNK1). Homozygous disruption of the gene encoding WNK1 results in lethality in mice near embryonic day E12 due to impaired angiogenesis, and this defect can be rescued by the endothelial-specific expression of an activated form of the WNK1 substrate kinase Oxidative Stress-Responsive 1 (OSR1). However, molecular processes regulated via a collaboration between TGF-β and WNK1/OSR1 are not well understood. Here, we show that WNK1 interacts with the E3 ubiquitin ligases SMURF1/2. In addition, we discovered that WNK1 regulates SMURF1/2 protein stability and vice versa. We also demonstrate that WNK1 activity regulates TGF-β receptor levels, in turn, controlling TGF-β signaling.</p>","PeriodicalId":74042,"journal":{"name":"Kinases and phosphatases","volume":"2 3","pages":"294-305"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12392294/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ATM Kinase Small Molecule Inhibitors Prevent Radiation-Induced Apoptosis of Mouse Neurons In Vivo. ATM激酶小分子抑制剂在体内阻止辐射诱导的小鼠神经元凋亡。
Pub Date : 2024-09-01 Epub Date: 2024-09-18 DOI: 10.3390/kinasesphosphatases2030017
Yüksel Aydar, Sanara S Rambukkanage, Lauryn Brown, Juan Wang, Ji Sung Seo, Keming Li, Yong Cheng, Laura Biddlestone-Thorpe, Caila Boyd, Amrita Sule, Kristoffer Valerie

ATM kinase is becoming an important therapeutic target for tumor radiosensitization. Radiation is known to cause neuro-inflammation and neurodegeneration; however, the effects of small molecule ATM inhibitors (ATMi's) and radiation on normal tissue, including healthy brain, are largely unexplored. Therefore, we examined the mouse CNS after ATMi radiosensitization with a focus on the fate of neurons. We used several approaches to assess the effects on the DNA damage response (DDR) and apoptosis of neurons using immunostaining. In vivo, a significant decrease in viable neurons and increase in degenerating neurons and apoptosis was observed in mice treated with radiation alone. On the other hand, an ATMi alone had little to no effect on neuron viability and did not induce apoptosis. Importantly, the ATMi's did not further increase radiation toxicity. In fact, multiplex immunostaining showed that a clinical candidate ATMi (AZD1390) protected mouse neurons from apoptosis by 90% at 4 h after radiation. We speculate that the lack of toxicity to neurons is due to a normal ATM-p53 response that, if blocked transiently with an ATMi, is protective. Altogether, in line with previous work using ATM knockout mice, we provide evidence that ATM kinase inhibition using small molecules does not add to neuronal radiation toxicity, and might, in fact, protect them from radiation-induced apoptosis at least in the short term.

ATM激酶正成为肿瘤放射增敏的重要治疗靶点。已知辐射会引起神经炎症和神经变性;然而,小分子ATM抑制剂(ATMi's)和辐射对正常组织(包括健康的大脑)的影响在很大程度上尚未被探索。因此,我们检查了ATMi放射致敏后的小鼠中枢神经系统,重点关注神经元的命运。我们使用了几种方法来评估免疫染色对神经元DNA损伤反应(DDR)和凋亡的影响。在体内,单独放疗小鼠存活神经元显著减少,变性神经元增多,细胞凋亡增多。另一方面,单独使用ATMi对神经元活力几乎没有影响,也不会诱导细胞凋亡。重要的是,ATMi并没有进一步增加辐射毒性。事实上,多重免疫染色显示,临床候选ATMi (AZD1390)在辐射后4小时保护小鼠神经元免于90%的凋亡。我们推测,对神经元缺乏毒性是由于正常的ATM-p53反应,如果被ATMi短暂阻断,则具有保护作用。总之,与之前使用ATM敲除小鼠的工作一致,我们提供的证据表明,使用小分子抑制ATM激酶不会增加神经元的辐射毒性,实际上可能至少在短期内保护它们免受辐射诱导的细胞凋亡。
{"title":"ATM Kinase Small Molecule Inhibitors Prevent Radiation-Induced Apoptosis of Mouse Neurons In Vivo.","authors":"Yüksel Aydar, Sanara S Rambukkanage, Lauryn Brown, Juan Wang, Ji Sung Seo, Keming Li, Yong Cheng, Laura Biddlestone-Thorpe, Caila Boyd, Amrita Sule, Kristoffer Valerie","doi":"10.3390/kinasesphosphatases2030017","DOIUrl":"https://doi.org/10.3390/kinasesphosphatases2030017","url":null,"abstract":"<p><p>ATM kinase is becoming an important therapeutic target for tumor radiosensitization. Radiation is known to cause neuro-inflammation and neurodegeneration; however, the effects of small molecule ATM inhibitors (ATMi's) and radiation on normal tissue, including healthy brain, are largely unexplored. Therefore, we examined the mouse CNS after ATMi radiosensitization with a focus on the fate of neurons. We used several approaches to assess the effects on the DNA damage response (DDR) and apoptosis of neurons using immunostaining. In vivo, a significant decrease in viable neurons and increase in degenerating neurons and apoptosis was observed in mice treated with radiation alone. On the other hand, an ATMi alone had little to no effect on neuron viability and did not induce apoptosis. Importantly, the ATMi's did not further increase radiation toxicity. In fact, multiplex immunostaining showed that a clinical candidate ATMi (AZD1390) protected mouse neurons from apoptosis by 90% at 4 h after radiation. We speculate that the lack of toxicity to neurons is due to a normal ATM-p53 response that, if blocked transiently with an ATMi, is protective. Altogether, in line with previous work using ATM knockout mice, we provide evidence that ATM kinase inhibition using small molecules does not add to neuronal radiation toxicity, and might, in fact, protect them from radiation-induced apoptosis at least in the short term.</p>","PeriodicalId":74042,"journal":{"name":"Kinases and phosphatases","volume":"2 3","pages":"268-278"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11981642/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144054841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protein Kinases in Copper Homeostasis: A Review on Cu+-ATPase Modulation 铜平衡中的蛋白激酶:Cu+-ATPase 调节综述
Pub Date : 2024-07-25 DOI: 10.3390/kinasesphosphatases2030015
R. Valverde, Jennifer Lowe
Copper is an essential heavy metal for diverse biological functions but toxic in excess. Consequently, a tightly regulated protein system is required to ensure adequate intracellular levels. In recent decades, several studies have explored the role of Cu+-ATPases in copper transport and homeostasis, revealing that these proteins are subject to kinase-mediated phosphorylation that significantly impacts their function. Techniques such as phosphoproteomic screening, site-directed mutagenesis, and artificial neural network tools demonstrated the regulatory effect of phosphorylation on these ATPases. Different protein kinases regulate Cu+-ATPases, modulating the active copper transport by affecting specific steps of the catalytic cycle, long-range intramolecular crosstalks, protein trafficking, gene expression, and protein stability. Therefore, the regulatory phosphorylation of Cu+-ATPases by kinases ultimately influences the intracellular copper distribution. This study aims to present a review of the scientific literature on the regulation of Cu+-ATPases by kinase-mediated phosphorylation as a crucial mechanism for copper homeostasis. This regulation offers new perspectives for developing therapies for disorders related to copper metabolism, such as Wilson and Menkes diseases, as well as cancer, diabetes mellitus, Parkinson’s, and Alzheimer’s diseases. These findings emphasize the need to further comprehend the signaling pathways involving protein kinases in the context of copper regulation.
铜是多种生物功能所必需的重金属,但过量则会中毒。因此,需要一个严格调控的蛋白质系统来确保细胞内有足够的铜含量。近几十年来,一些研究探索了 Cu+-ATP 酶在铜转运和平衡中的作用,发现这些蛋白受激酶介导的磷酸化作用影响很大。磷酸化蛋白组筛选、定点突变和人工神经网络工具等技术证明了磷酸化对这些 ATP 酶的调控作用。不同的蛋白激酶调控 Cu+-ATP 酶,通过影响催化循环的特定步骤、长程分子内串联、蛋白质贩运、基因表达和蛋白质稳定性来调节活性铜转运。因此,激酶对 Cu+-ATP 酶的调节性磷酸化最终会影响细胞内铜的分布。本研究旨在综述有关激酶介导的磷酸化对 Cu+-ATP 酶的调控这一铜平衡关键机制的科学文献。这种调控为开发治疗与铜代谢有关的疾病(如威尔逊病、门克氏症、癌症、糖尿病、帕金森病和阿尔茨海默病)的疗法提供了新的视角。这些发现强调了进一步理解铜调节中涉及蛋白激酶的信号通路的必要性。
{"title":"Protein Kinases in Copper Homeostasis: A Review on Cu+-ATPase Modulation","authors":"R. Valverde, Jennifer Lowe","doi":"10.3390/kinasesphosphatases2030015","DOIUrl":"https://doi.org/10.3390/kinasesphosphatases2030015","url":null,"abstract":"Copper is an essential heavy metal for diverse biological functions but toxic in excess. Consequently, a tightly regulated protein system is required to ensure adequate intracellular levels. In recent decades, several studies have explored the role of Cu+-ATPases in copper transport and homeostasis, revealing that these proteins are subject to kinase-mediated phosphorylation that significantly impacts their function. Techniques such as phosphoproteomic screening, site-directed mutagenesis, and artificial neural network tools demonstrated the regulatory effect of phosphorylation on these ATPases. Different protein kinases regulate Cu+-ATPases, modulating the active copper transport by affecting specific steps of the catalytic cycle, long-range intramolecular crosstalks, protein trafficking, gene expression, and protein stability. Therefore, the regulatory phosphorylation of Cu+-ATPases by kinases ultimately influences the intracellular copper distribution. This study aims to present a review of the scientific literature on the regulation of Cu+-ATPases by kinase-mediated phosphorylation as a crucial mechanism for copper homeostasis. This regulation offers new perspectives for developing therapies for disorders related to copper metabolism, such as Wilson and Menkes diseases, as well as cancer, diabetes mellitus, Parkinson’s, and Alzheimer’s diseases. These findings emphasize the need to further comprehend the signaling pathways involving protein kinases in the context of copper regulation.","PeriodicalId":74042,"journal":{"name":"Kinases and phosphatases","volume":"52 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141805455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dynamic Equilibrium of Protein Phosphorylation by Kinases and Phosphatases Visualized by Phos-Tag SDS-PAGE 通过 Phos-Tag SDS-PAGE 观察激酶和磷酸酶磷酸化的动态平衡
Pub Date : 2024-07-19 DOI: 10.3390/kinasesphosphatases2030014
Emiko Kinoshita-Kikuta, Kento Nishikawa, Kento Hiraishi, Kaku Shimoji, Kenichi Nagase, Eiji Kinoshita
The phosphorylation state of 20 types of intracellular proteins in the presence of the protein phosphatase 1 (PP1)- and PP2A-specific Ser/Thr phosphatase inhibitor calyculin A or the Tyr phosphatase inhibitor pervanadate was visualized by Phos-tag SDS-PAGE followed by immunoblotting. All blots showed a Phos-tag pattern indicating increased phosphorylation in the presence of one or both phosphatase inhibitors. The increase in phosphorylation stoichiometry per protein tends to be greater for Ser/Thr phosphatase inhibition than for Tyr phosphatase inhibition. This is consistent with the fact that the number of Ser/Thr kinase genes in the human genome is greater than that of Tyr kinases and with the fact that the phospho-Ser/phospho-Thr ratio in the actual human phosphoproteome is far greater than that of phospho-Tyr ratio. This suggests that cellular proteins are routinely and randomly phosphorylated by different kinases with no biological significance, simply depending on the frequency of substrate encounters. Phosphatase is responsible for routinely removing these unwanted phosphate groups systematically and maintaining the dynamic equilibrium of physiological protein phosphorylation. Phos-tag SDS-PAGE visualized that the kinase reaction involves many incidental phosphorylation and that phosphatases play broader roles besides being strict counterparts to kinases.
在蛋白磷酸酶 1(PP1)和 PP2A 特异性 Ser/Thr 磷酸酶抑制剂钙黄绿素 A 或 Tyr 磷酸酶抑制剂 pervanadate 的存在下,通过 Phos-tag SDS-PAGE 和免疫印迹观察 20 种细胞内蛋白质的磷酸化状态。所有印迹都显示出 Phos-tag 模式,表明在一种或两种磷酸酶抑制剂存在的情况下磷酸化增加。在抑制 Ser/Thr 磷酸酶的情况下,每个蛋白质的磷酸化比例的增加往往大于抑制 Tyr 磷酸酶的情况。这与人类基因组中 Ser/Thr 激酶基因的数量多于 Tyr 激酶基因的数量,以及实际人类磷酸化蛋白质组中磷酸化-Ser/磷酸化-Thr 比率远大于磷酸化-Tyr 比率的事实是一致的。这表明,细胞蛋白质经常被不同的激酶随机磷酸化,这并不具有生物学意义,只是取决于遇到底物的频率。磷酸酶负责定期系统地清除这些不需要的磷酸基团,维持生理蛋白质磷酸化的动态平衡。Phos-tag SDS-PAGE 显示,激酶反应涉及许多偶然的磷酸化,磷酸酶除了严格对应激酶外,还发挥着更广泛的作用。
{"title":"Dynamic Equilibrium of Protein Phosphorylation by Kinases and Phosphatases Visualized by Phos-Tag SDS-PAGE","authors":"Emiko Kinoshita-Kikuta, Kento Nishikawa, Kento Hiraishi, Kaku Shimoji, Kenichi Nagase, Eiji Kinoshita","doi":"10.3390/kinasesphosphatases2030014","DOIUrl":"https://doi.org/10.3390/kinasesphosphatases2030014","url":null,"abstract":"The phosphorylation state of 20 types of intracellular proteins in the presence of the protein phosphatase 1 (PP1)- and PP2A-specific Ser/Thr phosphatase inhibitor calyculin A or the Tyr phosphatase inhibitor pervanadate was visualized by Phos-tag SDS-PAGE followed by immunoblotting. All blots showed a Phos-tag pattern indicating increased phosphorylation in the presence of one or both phosphatase inhibitors. The increase in phosphorylation stoichiometry per protein tends to be greater for Ser/Thr phosphatase inhibition than for Tyr phosphatase inhibition. This is consistent with the fact that the number of Ser/Thr kinase genes in the human genome is greater than that of Tyr kinases and with the fact that the phospho-Ser/phospho-Thr ratio in the actual human phosphoproteome is far greater than that of phospho-Tyr ratio. This suggests that cellular proteins are routinely and randomly phosphorylated by different kinases with no biological significance, simply depending on the frequency of substrate encounters. Phosphatase is responsible for routinely removing these unwanted phosphate groups systematically and maintaining the dynamic equilibrium of physiological protein phosphorylation. Phos-tag SDS-PAGE visualized that the kinase reaction involves many incidental phosphorylation and that phosphatases play broader roles besides being strict counterparts to kinases.","PeriodicalId":74042,"journal":{"name":"Kinases and phosphatases","volume":"104 24","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141821889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exogenous and Endogenous Molecules Potentially Proficient to Modulate Mitophagy in Cardiac Disorders 外源性和内源性分子可能有助于调节心脏疾病中的有丝分裂
Pub Date : 2024-05-23 DOI: 10.3390/kinasesphosphatases2020010
Moeka Nakashima, Naoko Suga, Satoru Matsuda
It has been proposed that procedures which upregulate mitochondrial biogenesis and autophagy by replacing damaged mitochondria with healthy ones may prevent the development of several heart diseases. A member of serine and threonine kinases, adenosine monophosphate-activated protein kinase (AMPK), could play essential roles in the autophagy and/or mitophagy. AMPK is widely distributed in various cells, which might play diverse regulatory roles in different tissues and/or organs. In fact, changes in the kinase function of AMPK due to alteration of activity have been linked with diverse pathologies including cardiac disorders. AMPK can regulate mitochondrial biogenesis via peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) signaling and also improve oxidative mitochondrial metabolism through inhibition of mechanistic/mammalian target of rapamycin (mTOR) pathway, which may also modulate the autophagy/mitophagy through autophagy activating kinase 1 (ULK1) and/or transforming growth factor beta (TGF-β) signaling. Therefore, the modulation of AMPK in autophagy/mitophagy pathway might probably be thought as a therapeutic tactic for several cardiac disorders. As kinases are amongst the most controllable proteins, in general, the design of small molecules targeting kinases might be an eye-catching avenue to modulate cardiac function. Some analyses of the molecular biology underlying mitophagy suggest that nutraceuticals and/or drugs including specific AMPK modulator as well as physical exercise and/or dietary restriction that could modulate AMPK may be useful against several heart diseases. These observations may virtually be limited to preclinical studies. Come to think of these, however, it is speculated that some nutraceutical regimens might have positive potential for managing some of cardiac disorders.
有人提出,通过用健康的线粒体取代受损的线粒体来上调线粒体生物生成和自噬过程,可以预防多种心脏病的发生。丝氨酸和苏氨酸激酶的一个成员--单磷酸腺苷激活的蛋白激酶(AMPK)在自噬和/或有丝分裂中可能发挥重要作用。AMPK 广泛分布于各种细胞中,可能在不同组织和/或器官中发挥不同的调节作用。事实上,AMPK 激酶功能的改变与包括心脏疾病在内的多种病症有关。AMPK可通过过氧化物酶体增殖激活受体γ辅助激活剂1-α(PGC1α)信号调节线粒体生物生成,还可通过抑制雷帕霉素机制/哺乳动物靶标(mTOR)通路改善线粒体氧化代谢,还可通过自噬激活激酶1(ULK1)和/或转化生长因子β(TGF-β)信号调节自噬/介噬。因此,调节自噬/介噬通路中的 AMPK 可能被认为是治疗多种心脏疾病的一种策略。一般来说,激酶是最容易控制的蛋白质之一,因此设计以激酶为靶点的小分子药物可能是调节心脏功能的一个引人注目的途径。对有丝分裂的分子生物学基础进行的一些分析表明,营养保健品和/或药物(包括特定的 AMPK 调节剂)以及可以调节 AMPK 的体育锻炼和/或饮食限制可能有助于防治多种心脏疾病。这些观察结果可能仅限于临床前研究。不过,我们可以推测,一些营养保健品可能对治疗某些心脏疾病具有积极的潜力。
{"title":"Exogenous and Endogenous Molecules Potentially Proficient to Modulate Mitophagy in Cardiac Disorders","authors":"Moeka Nakashima, Naoko Suga, Satoru Matsuda","doi":"10.3390/kinasesphosphatases2020010","DOIUrl":"https://doi.org/10.3390/kinasesphosphatases2020010","url":null,"abstract":"It has been proposed that procedures which upregulate mitochondrial biogenesis and autophagy by replacing damaged mitochondria with healthy ones may prevent the development of several heart diseases. A member of serine and threonine kinases, adenosine monophosphate-activated protein kinase (AMPK), could play essential roles in the autophagy and/or mitophagy. AMPK is widely distributed in various cells, which might play diverse regulatory roles in different tissues and/or organs. In fact, changes in the kinase function of AMPK due to alteration of activity have been linked with diverse pathologies including cardiac disorders. AMPK can regulate mitochondrial biogenesis via peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) signaling and also improve oxidative mitochondrial metabolism through inhibition of mechanistic/mammalian target of rapamycin (mTOR) pathway, which may also modulate the autophagy/mitophagy through autophagy activating kinase 1 (ULK1) and/or transforming growth factor beta (TGF-β) signaling. Therefore, the modulation of AMPK in autophagy/mitophagy pathway might probably be thought as a therapeutic tactic for several cardiac disorders. As kinases are amongst the most controllable proteins, in general, the design of small molecules targeting kinases might be an eye-catching avenue to modulate cardiac function. Some analyses of the molecular biology underlying mitophagy suggest that nutraceuticals and/or drugs including specific AMPK modulator as well as physical exercise and/or dietary restriction that could modulate AMPK may be useful against several heart diseases. These observations may virtually be limited to preclinical studies. Come to think of these, however, it is speculated that some nutraceutical regimens might have positive potential for managing some of cardiac disorders.","PeriodicalId":74042,"journal":{"name":"Kinases and phosphatases","volume":"7 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141105426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer Stem Cell Metastatic Checkpoints and Glycosylation Patterns: Implications for Therapeutic Strategies 癌症干细胞转移检查点和糖基化模式:治疗策略的意义
Pub Date : 2024-04-22 DOI: 10.3390/kinasesphosphatases2020009
S. Aghamiri, Rada Amin
Cancer stem cells (CSCs), found within tumors, are powerful drivers of disease recurrence and metastasis. Their abilities to self-renew and maintain stem-like properties make treatment difficult, as their heterogeneity and metastatic properties can lead to resistance and limit the effectiveness of standard therapies. Given their significance, CSCs are typically isolated based on combinations of markers, which often indicate heterogeneous populations of CSCs. The lack of consensus in cell characterization poses challenges in defining and targeting these cells for effective therapeutic interventions. In this review, we suggest five promising molecules—ABCB5, CD26, CD66c, uPAR, and Trop-2—chosen specifically for their distinct distribution within cancer types and clinical relevance. These markers, expressed at the cell surface of CSCs, could significantly enhance the specificity of cancer stemness characterization. This review focuses on describing their pivotal roles as biomarker checkpoints for metastasis. Additionally, this review outlines existing literature on glycosylation modifications, which present intriguing epitopes aimed at modulating the stability and function of these markers. Finally, we summarize several promising in vivo and clinical trial approaches targeting the mentioned surface markers, offering potential solutions to overcome the therapeutic resistance of CSCs and addressing current gaps in treatment strategies.
肿瘤内的癌症干细胞(CSCs)是疾病复发和转移的强大驱动力。它们具有自我更新和保持干细胞特性的能力,这给治疗带来了困难,因为它们的异质性和转移特性会导致抗药性,限制标准疗法的有效性。鉴于其重要性,CSCs 通常根据标记物的组合进行分离,而这些标记物往往显示 CSCs 的异质性群体。细胞特征描述缺乏共识,这给定义和靶向这些细胞以进行有效的治疗干预带来了挑战。在这篇综述中,我们提出了五种有前景的分子--ABCB5、CD26、CD66c、uPAR 和 Trop-2--它们因其在癌症类型中的独特分布和临床相关性而被特别选中。这些在癌干细胞表面表达的标志物可显著提高癌症干性特征描述的特异性。本综述将重点描述它们作为转移生物标记检查点的关键作用。此外,本综述还概述了有关糖基化修饰的现有文献,这些文献提供了旨在调节这些标记物稳定性和功能的有趣表位。最后,我们总结了针对上述表面标志物的几种有前景的体内和临床试验方法,为克服造血干细胞的耐药性和解决当前治疗策略的不足提供了潜在的解决方案。
{"title":"Cancer Stem Cell Metastatic Checkpoints and Glycosylation Patterns: Implications for Therapeutic Strategies","authors":"S. Aghamiri, Rada Amin","doi":"10.3390/kinasesphosphatases2020009","DOIUrl":"https://doi.org/10.3390/kinasesphosphatases2020009","url":null,"abstract":"Cancer stem cells (CSCs), found within tumors, are powerful drivers of disease recurrence and metastasis. Their abilities to self-renew and maintain stem-like properties make treatment difficult, as their heterogeneity and metastatic properties can lead to resistance and limit the effectiveness of standard therapies. Given their significance, CSCs are typically isolated based on combinations of markers, which often indicate heterogeneous populations of CSCs. The lack of consensus in cell characterization poses challenges in defining and targeting these cells for effective therapeutic interventions. In this review, we suggest five promising molecules—ABCB5, CD26, CD66c, uPAR, and Trop-2—chosen specifically for their distinct distribution within cancer types and clinical relevance. These markers, expressed at the cell surface of CSCs, could significantly enhance the specificity of cancer stemness characterization. This review focuses on describing their pivotal roles as biomarker checkpoints for metastasis. Additionally, this review outlines existing literature on glycosylation modifications, which present intriguing epitopes aimed at modulating the stability and function of these markers. Finally, we summarize several promising in vivo and clinical trial approaches targeting the mentioned surface markers, offering potential solutions to overcome the therapeutic resistance of CSCs and addressing current gaps in treatment strategies.","PeriodicalId":74042,"journal":{"name":"Kinases and phosphatases","volume":"37 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140676263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-Chain Fatty Acids Suppress mTOR Signaling in Colon Cancer Cells via Long Non-Coding RNA RMST 短链脂肪酸通过长非编码 RNA RMST 抑制结肠癌细胞中的 mTOR 信号传导
Pub Date : 2024-04-01 DOI: 10.3390/kinasesphosphatases2020008
Jiuhui Wang, Yande Guo, Xiangwei Fang, Yuanqin Zhang, D. Nie
Short-chain fatty acids (SCFAs), derived from fermentation of dietary fibers and resistant starch by the microbiota in the colon, exert multiple effects on colonic functions, including tumor suppressing activities. Our previous studies found that SCFAs induced autophagy in colon cancer cells via downregulating mTOR signaling, but the mechanism involved in mTOR suppression still needs to be defined. In this study, we identified rhabdomyosarcoma 2 associated transcript (RMST), a long non-coding RNA, as a key mediator for SCFAs to suppress mTOR activation in colon cancer cells. RMST could be significantly induced by SCFAs in a time- and dose-dependent manner. RMST, by itself, was sufficient to suppress mTOR signaling and augment autophagosome formation. Depletion of RMST, through siRNA or CRISPR knockdown, reduced the abilities of SCFAs to suppress mTOR activation or to induce autophagic responses. RMST increased the expression level of TSC2, a negative regulator of the mTOR signaling pathway. Our data delineate a novel RMST/TSC2 cellular pathway, enlisted by SCFAs, to modulate mTOR activities in colon cancer cells.
短链脂肪酸(SCFAs)由结肠中的微生物群对膳食纤维和抗性淀粉发酵产生,对结肠功能有多种影响,包括抑制肿瘤活性。我们之前的研究发现,SCFAs 可通过下调 mTOR 信号诱导结肠癌细胞自噬,但其抑制 mTOR 的机制仍有待明确。在这项研究中,我们发现横纹肌肉瘤2相关转录物(RMST)是一种长非编码RNA,是SCFAs抑制结肠癌细胞mTOR激活的关键介质。SCFAs能以时间和剂量依赖的方式显著诱导RMST。RMST本身足以抑制mTOR信号转导并促进自噬体的形成。通过siRNA或CRISPR敲除RMST会降低SCFAs抑制mTOR激活或诱导自噬反应的能力。RMST 提高了 mTOR 信号通路负调控因子 TSC2 的表达水平。我们的数据勾勒出了一种新型的 RMST/TSC2 细胞通路,SCFAs 可用于调节结肠癌细胞中的 mTOR 活性。
{"title":"Short-Chain Fatty Acids Suppress mTOR Signaling in Colon Cancer Cells via Long Non-Coding RNA RMST","authors":"Jiuhui Wang, Yande Guo, Xiangwei Fang, Yuanqin Zhang, D. Nie","doi":"10.3390/kinasesphosphatases2020008","DOIUrl":"https://doi.org/10.3390/kinasesphosphatases2020008","url":null,"abstract":"Short-chain fatty acids (SCFAs), derived from fermentation of dietary fibers and resistant starch by the microbiota in the colon, exert multiple effects on colonic functions, including tumor suppressing activities. Our previous studies found that SCFAs induced autophagy in colon cancer cells via downregulating mTOR signaling, but the mechanism involved in mTOR suppression still needs to be defined. In this study, we identified rhabdomyosarcoma 2 associated transcript (RMST), a long non-coding RNA, as a key mediator for SCFAs to suppress mTOR activation in colon cancer cells. RMST could be significantly induced by SCFAs in a time- and dose-dependent manner. RMST, by itself, was sufficient to suppress mTOR signaling and augment autophagosome formation. Depletion of RMST, through siRNA or CRISPR knockdown, reduced the abilities of SCFAs to suppress mTOR activation or to induce autophagic responses. RMST increased the expression level of TSC2, a negative regulator of the mTOR signaling pathway. Our data delineate a novel RMST/TSC2 cellular pathway, enlisted by SCFAs, to modulate mTOR activities in colon cancer cells.","PeriodicalId":74042,"journal":{"name":"Kinases and phosphatases","volume":"40 36","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140771714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CK2 Inhibitors Targeting Inside and Outside the Catalytic Box 针对催化盒内外的 CK2 抑制剂
Pub Date : 2024-03-26 DOI: 10.3390/kinasesphosphatases2020007
Sophie Day-Riley, Rebekah M. West, P. Brear, M. Hyvönen, D. Spring
CK2 is a protein kinase that plays an important role in numerous cellular pathways involved in cell growth, differentiation, proliferation, and death. Consequently, upregulation of CK2 is implicated in many disease types, in particular cancer. As such, CK2 has gained significant attention as a potential therapeutic target in cancer, and over 40 chemical probes targeting CK2 have been developed in the past decade. In this review, we highlighted several chemical probes that target sites outside the conventional ATP-binding site. These chemical probes belong to different classes of molecules, from small molecules to peptides, and possess different mechanisms of action. Many of the chemical probes discussed in this review could serve as promising new candidates for drugs selectively targeting CK2.
CK2 是一种蛋白激酶,在涉及细胞生长、分化、增殖和死亡的众多细胞通路中发挥着重要作用。因此,CK2 的上调与许多疾病类型有关,尤其是癌症。因此,CK2 作为癌症的潜在治疗靶点受到了广泛关注,在过去十年中,已经开发出 40 多种针对 CK2 的化学探针。在本综述中,我们重点介绍了几种针对传统 ATP 结合位点以外位点的化学探针。这些化学探针属于不同的分子类别,从小分子到多肽,具有不同的作用机制。本综述中讨论的许多化学探针都有可能成为选择性靶向 CK2 的候选药物。
{"title":"CK2 Inhibitors Targeting Inside and Outside the Catalytic Box","authors":"Sophie Day-Riley, Rebekah M. West, P. Brear, M. Hyvönen, D. Spring","doi":"10.3390/kinasesphosphatases2020007","DOIUrl":"https://doi.org/10.3390/kinasesphosphatases2020007","url":null,"abstract":"CK2 is a protein kinase that plays an important role in numerous cellular pathways involved in cell growth, differentiation, proliferation, and death. Consequently, upregulation of CK2 is implicated in many disease types, in particular cancer. As such, CK2 has gained significant attention as a potential therapeutic target in cancer, and over 40 chemical probes targeting CK2 have been developed in the past decade. In this review, we highlighted several chemical probes that target sites outside the conventional ATP-binding site. These chemical probes belong to different classes of molecules, from small molecules to peptides, and possess different mechanisms of action. Many of the chemical probes discussed in this review could serve as promising new candidates for drugs selectively targeting CK2.","PeriodicalId":74042,"journal":{"name":"Kinases and phosphatases","volume":"28 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140378420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Importance of Kinases in Retinal Degenerative Diseases 激酶在视网膜退行性疾病中的重要性
Pub Date : 2024-02-25 DOI: 10.3390/kinasesphosphatases2010006
P. F. Santos, António Francisco Ambrósio, Hélène Léger
Kinases play crucial roles in the pathophysiology of retinal degenerative diseases. These diseases, such as diabetic retinopathy, age-related macular degeneration, glaucoma, and retinitis pigmentosa, are characterized by progressive degeneration of retinal cells, including photoreceptors, ganglion cells, vascular cells, and retinal pigment epithelium, among others. The involvement of kinases in cell survival and apoptosis, immune responses and inflammation regulation, mitochondrial functions and mitophagy, autophagy, and proteostasis is crucial for maintaining cellular homeostasis and responding to various stressors. This review highlights the importance of studying kinases to better understand their functions and, regulation permitting, enable the identification of novel molecular players or potential drug targets and, consequently, the development of more effective and precise treatments to slow or halt the progression of retinal degenerative diseases.
激酶在视网膜变性疾病的病理生理学中起着至关重要的作用。糖尿病视网膜病变、老年性黄斑变性、青光眼和视网膜色素变性等这些疾病的特征是视网膜细胞逐渐退化,包括感光细胞、神经节细胞、血管细胞和视网膜色素上皮细胞等。激酶参与细胞存活和凋亡、免疫反应和炎症调节、线粒体功能和有丝分裂、自噬以及蛋白稳态,这对于维持细胞稳态和应对各种压力至关重要。这篇综述强调了研究激酶的重要性,以便更好地了解它们的功能,并在调节允许的情况下确定新的分子角色或潜在的药物靶点,从而开发出更有效、更精确的治疗方法来减缓或阻止视网膜退行性疾病的进展。
{"title":"The Importance of Kinases in Retinal Degenerative Diseases","authors":"P. F. Santos, António Francisco Ambrósio, Hélène Léger","doi":"10.3390/kinasesphosphatases2010006","DOIUrl":"https://doi.org/10.3390/kinasesphosphatases2010006","url":null,"abstract":"Kinases play crucial roles in the pathophysiology of retinal degenerative diseases. These diseases, such as diabetic retinopathy, age-related macular degeneration, glaucoma, and retinitis pigmentosa, are characterized by progressive degeneration of retinal cells, including photoreceptors, ganglion cells, vascular cells, and retinal pigment epithelium, among others. The involvement of kinases in cell survival and apoptosis, immune responses and inflammation regulation, mitochondrial functions and mitophagy, autophagy, and proteostasis is crucial for maintaining cellular homeostasis and responding to various stressors. This review highlights the importance of studying kinases to better understand their functions and, regulation permitting, enable the identification of novel molecular players or potential drug targets and, consequently, the development of more effective and precise treatments to slow or halt the progression of retinal degenerative diseases.","PeriodicalId":74042,"journal":{"name":"Kinases and phosphatases","volume":"53 158","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140432543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Kinases and phosphatases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1